Min Jung Park, MD, PhD 2 Young Kon Kim, MD, PhD Sanghyeok Lim, MD Hyunchul Rhim, MD, PhD Won Jae Lee, MD, PhD. Purpose: Materials and Methods:
|
|
- Laurence Owens
- 5 years ago
- Views:
Transcription
1 Note: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at Original Research n Gastrointestinal Imaging Min Jung Park, MD, PhD 2 Young Kon Kim, MD, PhD Sanghyeok Lim, MD Hyunchul Rhim, MD, PhD Won Jae Lee, MD, PhD Hilar Cholangiocarcinoma: Value of Adding DW Imaging to Gadoxetic Acid enhanced MR Imaging with MR Cholangiopancreatography for Preoperative Evaluation 1 Purpose: Materials and Methods: To assess the benefit of adding diffusion-weighted (DW) imaging to gadoxetic acid enhanced magnetic resonance (MR) imaging and MR cholangiopancreatography in the preoperative evaluation of hilar cholangiocarcinoma. The institutional review board approved this retrospective study and waived the requirement for informed consent. The study included 52 patients (36 men, 16 women; mean age, 63.4 years) with surgically confirmed hilar cholangiocarcinoma who underwent gadoxetic acid enhanced MR imaging and DW imaging at 3.0 T between August 2010 and December Two observers independently reviewed two image sets a gadoxetic acid set, including images from MR cholangiopancreatography, and a combined gadoxetic acid set and DW imaging set to evaluate the tumor involvement of each biliary confluence and vascular and liver invasion by using receiver operating characteristic (ROC) curve analysis. 1 From the Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong, Gangnam-gu, Seoul , Republic of Korea. Received January 2, 2013; revision requested February 1; revision received April 3; accepted April 16; final version accepted August 13. Address correspondence to Y.K.K. ( jmyr@dreamwiz.com). 2 Current address: Department of Radiology, Yonsei University College of Medicine, Seoul, Korea. q RSNA, 2013 Results: Conclusion: For each observer, area under the ROC curve (A z ) values for tumor involvement of the biliary confluence were and for the gadoxetic acid set and and for the combined set, respectively (P..05). For detecting 105 biliary confluences with tumor involvement, the sensitivities with the combined set (97.1% [102 of 105] and 98.1% [103 of 105]) were higher than those with the gadoxetic acid set (91.4% [96 of 105] for both observers) (P =.029 and P =.016), although the specificities were similar with both image sets (P..05). For the detection of liver invasion, the combined set (75.0% [15 of 20] for both observers) yielded better sensitivity than the gadoxetic acid set (50.0% [10 of 20] and 45.0% [nine of 20]) (P =.016 and P =.031). For evaluation of vascular invasion, the two image sets showed similar diagnostic performance. In the preoperative evaluation of hilar cholangiocarcinoma, the addition of DW imaging to gadoxetic acid enhanced MR imaging could improve sensitivity in the evaluation of tumor extent along the bile duct and liver invasion. q RSNA, 2013 Online supplemental material is available for this article. 768 radiology.rsna.org n Radiology: Volume 270: Number 3 March 2014
2 Hilar cholangiocarcinoma is an adenocarcinoma that occurs at the confluence of the right and left hepatic ducts at the liver hilum. It can be cured only with surgical resection. However, because of the locally advanced nature of this disease at presentation and its association with critical hepatobiliary structures, surgical resectability rates had traditionally been low (,30%) (1), and surgery rendered limited benefit (2 4). In recent decades, with the improved resolution of hepatic imaging, partial Advances in Knowledge nn In the preoperative evaluation of the biliary confluence in patients with hilar cholangiocarcinoma, gadoxetic acid enhanced MR imaging yielded diagnostic performance, with mean area under the receiver operating characteristic curve of (standard deviation) for observer 1 and for observer 2. nn The combination of gadoxetic acid enhanced MR imaging and diffusion-weighted (DW) imaging yields better sensitivity in the detection of tumor involvement in the biliary confluence than gadoxetic acid enhanced MR imaging alone (97.1% [102 of 105] vs 91.4% [96 of 105] for observer 1 [P =.029] and 98.1% [103 of 105] vs 91.4% [96 of 105] for observer 2 [P =.016]), although specificities were similar for both image sets (P..99). nn In the detection of liver invasion by hilar cholangiocarcinoma, the combination of gadoxetic acid enhanced MR imaging and DW imaging yielded better sensitivity than gadoxetic acid enhanced MR imaging alone (75.0% [15 of 20] vs 50.0% [10 of 20] for observer 1 [P =.016] and 75.0% [15 of 20] vs 45.0% [nine of 20] for observer 2 [P =.031]). hepatectomy has been added to the traditional surgical strategy, which consisted of resection of the bile duct with biliary-enteric anastomosis of the intrahepatic ducts. Accordingly, currently approximately 40% of patients with hilar cholangiocarcinoma may undergo surgical resection with curative intent, which has achieved 5-year survival rates of 11% 40% (1,5 9). The pathologic margin status is a strong risk factor influencing recurrence-free survival after resection of hilar cholangiocarcinoma (9 12). Therefore, the precise localization and determination of tumor extent along the bile duct, as well as in adjacent organs and vessels, is of paramount importance for surgical planning to achieve microscopically complete resection of hilar cholangiocarcinoma. Because of recent advances in magnetic resonance (MR) imaging technology, particularly the introduction of multichannel surface receiver coils and parallel imaging, diffusion-weighted (DW) imaging has been increasingly applied to liver MR imaging with improved image quality. To our knowledge, only one study (13) has documented the usefulness of DW imaging in the diagnosis of extrahepatic bile duct cancer. Because it offers high contrast between tumor and surrounding normal tissue, we hypothesized that DW imaging would add value to conventional liver MR imaging sequences, including MR cholangiopancreatography, in assessing the extent of hilar cholangiocarcinoma. Therefore, we performed this study to assess the incremental benefit of adding DW imaging to gadoxetic acid enhanced MR imaging and MR cholangiopancreatography in the preoperative Implication for Patient Care nn For the evaluation of hilar cholangiocarcinoma, DW imaging should be routinely included in the gadoxetic acid enhanced MR imaging protocol for detection of tumor extent along the bile duct and for detection of liver invasion. evaluation of hilar cholangiocarcinoma, with emphasis on tumor extent. Materials and Methods Study Population This retrospective study was approved by the institutional review board of Samsung Medical Center (Seoul, Korea), and the requirement for informed consent was waived. We searched our hospital s surgical database for the time period between August 2010 and December 2011 using the search phrase hilar cholangiocarcinoma and found 67 patients. The inclusion criteria were as follows: (a) preoperative gadoxetic acid enhanced liver MR imaging, including DW imaging and MR cholangiopancreatography; (b) surgery at our institution within 4 weeks after MR imaging; and (c) histologically confirmed hilar cholangiocarcinoma. Patients were excluded because of an absence of preoperative liver MR imaging (n = 9) and a time interval of more than 4 weeks between MR imaging and surgery (n = 6). Finally, 52 patients (mean age, 63.4 years; range, years; 36 men [mean age, 64 years; range, years] and 16 women [mean age, 62 years; range, years]) formed our study population. Among these patients, two had undergone percutaneous transhepatic biliary decompression Published online before print /radiol Content codes: Radiology 2014; 270: Abbreviations: ADC = apparent diffusion coefficient A z = area under the receiver operating characteristic curve CI = confidence interval DW = diffusion weighted HBP = hepatobiliary phase Author contributions: Guarantors of integrity of entire study, M.J.P., Y.K.K., S.L.; study concepts/study design or data acquisition or data analysis/interpretation, all authors; manuscript drafting or manuscript revision for important intellectual content, all authors; manuscript final version approval, all authors; literature research, M.J.P., Y.K.K., S.L.; clinical studies, all authors; statistical analysis, M.J.P., S.L.; and manuscript editing, all authors Conflicts of interest are listed at the end of this article. Radiology: Volume 270: Number 3 March 2014 n radiology.rsna.org 769
3 Table 1 MR Imaging Sequences and Parameters Imaging Sequence Repetition Time (msec)/echo Time (msec) Flip Angle (degrees) Section Thickness (mm) Matrix Size Bandwidth (Hz/pixel) Field of View (cm) Acquisition Time (sec) No. of Signals Acquired T1-weighted 3D dual GRE 3.5/ / Breath-hold multishot T2 weighted 1623/ / / Respiration-triggered single-shot 1156/ / heavily T2 weighted DW imaging 1600/ / T1-weighted 3D GRE 3.1/ / Breath-hold 2D MR 6417/ / cholangiopancreatography Navigator-triggered 3D MR cholangiopancreatography 1673/ / Note. GRE = gradient echo, 3D = three-dimensional, 2D = two-dimensional. procedures before MR imaging. The mean interval between the MR imaging examination and surgery was 12.4 days (range, 5 21 days). MR Imaging Examination All MR images were acquired by using a 3.0-T MR imaging system (Intera Achieva; Philips Healthcare, Best, the Netherlands) with a 16-channel phased-array receiver coil. MR imaging sequences are summarized in Table 1. MR cholangiopancreatography was performed by using two different methods a breath-hold two-dimensional single-projection turbo spin-echo MR cholangiopancreatography sequence performed at various angles (625, 15, 0 ) to the coronal plane and a navigator-triggered three-dimensional turbo spin-echo MR cholangiopancreatography sequence. DW imaging was performed by using respiratory-triggered single-shot echo planar imaging with b values of 0, 100, and 800 sec/mm 2. A spectral attenuated inversion-recovery technique was used for fat suppression at DW imaging. The apparent diffusion coefficient (ADC) was calculated with a monoexponential function by using b values of 100 and 800 sec/mm 2. For gadoxetic acid enhanced imaging, unenhanced, arterial phase, portal phase, 3-minute late phase, and 20-minute hepatobiliary phase (HBP) imaging was performed by using a T1-weighted three-dimensional turbo-field-echo sequence with a spectral attenuated inversion-recovery fatsuppression technique. The time for the arterial phase imaging was determined by using the MR fluoroscopic bolus detection technique. By using a power injector, mmol of the gadoxetic acid (Primovist; Bayer Healthcare, Berlin, Germany) per kilogram of body weight was administered intravenously at 1 ml/ sec, followed by a 20-mL saline flush. Image Analysis Two gastrointestinal radiologists (S.L. [observer 1] and Y.K.K. [observer 2], with 5 and 12 years of experience in liver MR imaging study interpretation, respectively), independently reviewed MR images for tumor involvement of each bile duct confluence and vascular and liver parenchymal invasion. They were blinded to the surgical and pathologic findings but were informed that the study population had hilar cholangiocarcinoma. The review consisted of separate sessions for the two image sets, with a 4-week interval. At the first session, the observers were randomly shown either (a) the gadoxetic acid set (precontrast T1- and T2-weighted images and gadoxetic acid enhanced arterial, portal, 3-minute delay, and 20-minute HBP images with MR cholangiopancreatography images) or (b) the combined gadoxetic acid set and DW images (DW images of b = 100 and 800 sec/mm 2 with ADC maps). In the second session, observers reviewed the image set they had not previously reviewed. To evaluate bile duct tumor involvement, the observers assigned a confidence level for each confluence (primary confluence and right and left secondary confluences) on the basis of a five-point scale as follows: A score of 1 indicated probably no tumor involvement; a score of 2, possibly no tumor involvement; a score of 3, indeterminate; a score of 4, probable tumor involvement; and a score of 5, definite tumor involvement. In the evaluation of vascular and liver parenchymal invasion, the observers assigned a classification of presence or absence of invasion. The MR imaging interpretation criteria for tumor involvement (14 18) in each image set are described in Appendix E1 (online). Because the spatial resolution of the DW images was inferior to that of the gadoxetic acid images, assessment of lesion localization was performed primarily with the gadoxetic acid set, and the DW imaging set was used for lesion characterization. When there was a discrepancy in the interpretations between the gadoxetic acid set and the DW imaging set, the observers were asked to give priority to the findings that drew higher observer confidence levels. Reference Standard The final diagnosis of all tumors was based on histopathologic examination of 770 radiology.rsna.org n Radiology: Volume 270: Number 3 March 2014
4 Table 2 Correlation of Bismuth- Corlette Classification of Hilar Cholangiocarcinoma at MR Imaging Study Interpretation and Pathologic Findings Observer and Bismuth-Corlette Classification Pathologic Tumor Classification II IIIa IIIb IV Observer 1 II 5/4 3/0 2/1 0 IIIa 2/3 21/25 0 3/2 IIIb 0 0 9/10 1/0 IV 0 2/1 0 4/6 Observer 2 II 5/5 3/0 2/1 0 IIIa 2/2 20/24 0 3/1 IIIb 0 0 9/10 1/0 IV 0 3/2 0 4/7 Total Table 3 Diagnostic Performance with Gadoxetic Acid MR Image Set and That with Combined DW and Gadoxetic Acid MR Image Set for Predicting Biliary Tumor Involvement on Per Bile Duct Confluence Basis Observer and Image Set A z Value* Sensitivity Specificity Observer 1 Gadoxetic acid set (0.922, 0.988) 91.4 [96/105] (85.9, 96.9) 92.2 [47/51] (83.7, 97.5) Combined set (0.953, 0.996) 97.1 [102/105] (93.2, 99.3) 92.2 [47/51] (84.1, 97.5) P value Observer 2 Gadoxetic acid set (0.905, 0.996) 91.4 [96/105] (85.9, 96.9) 90.2 [46/51] (77.8, 96.3) Combined set (0.935, 0.993) 98.1 [103/105] (94.9, 99.7) 92.2 [47/51] (83.7, 97.5) P value Note. P values were estimated by using nonparametric analysis of clustered receiver operating characteristic curve data or the generalized estimating equations method and were corrected with the Bonferroni method because of multiple testing. * A z = area under the receiver operating characteristic curve. Data are means 6 standard deviations, with 95% CIs in parentheses. Data in brackets are numbers of bile duct confluences; data in parentheses are 95% CIs Note. Data are numbers of tumors for the gadoxetic acid image set/for the combined image set. the surgical specimen and resection margin assessment. Six of 52 patients were noted as having microscopically positive resection margins in the final pathology reports (R1 resection), even though results of intraoperative frozen-section biopsies had indicated negative resection margins. In two other patients, palliative segmental bile duct resection with a positive resection margin (R2 resection) was performed. In these patients, intraoperative evaluation of the extent of bile duct tumor and vascular and liver involvement were also performed. Statistical Analysis For diagnostic performance in terms of bile duct tumor involvement, receiver operating characteristic curve analysis was performed and a pairwise comparison was made between the two image sets by using nonparametric analysis of clustered data (19). Only grades of 4 or 5 were considered positive for tumor involvement. For bile duct tumor involvement and vascular invasion, sensitivity, specificity, and accuracy were calculated and compared between the two image sets by using the clustered data method (20) and the generalized estimating equations method, respectively. For analyses of clustered data, 95% confidence intervals (CIs) and P values were corrected by using the Bonferroni method. For liver invasion, sensitivity, specificity, and accuracy were calculated, and a comparison was made between the image sets by using the McNemar test. k Scores were calculated to determine the degree of interobserver agreement. Statistical analyses were performed by using the statistics softwares MedCalc, version 11.4 (MedCalc Software, Mariakerke, Belgium) and SPSS, version 18.0 (SPSS, an IBM company, Chicago, Ill). Null hypotheses of no difference were rejected if P values were less than.05. Results According to the Bismuth-Corlette classification of hilar cholangiocarcinoma (Table E1 [online]), 26 of the 52 tumors were type IIIa, 11 were type IIIb, eight were type IV, and seven were type II (Table 2). Morphologically, the majority of the tumors (n = 44) were the periductal infiltrative type, and the remaining tumors were the periductal infiltrative type with mass formation in the liver (n = 2) or the intraductal growing type (n = 6). Bile Duct Involvement Among 156 bile duct confluences in 52 patients, 105 were found to have tumor involvement at histopathologic examination. All 52 tumors were hyperintense compared with liver parenchyma at both b = 100 sec/mm 2 and b = 800 sec/mm 2 DW imaging. As summarized in Table 3, for identifying tumor involvement of each bile duct confluence, both observers showed higher A z values in interpreting the combined set than in interpreting the gadoxetic acid set, although the difference was not statistically significant (0.980 vs for observer 1; vs for observer 2; P..05 for both observers) (Fig 1). Diagnostic accuracies were slightly higher for the combined set than for the gadoxetic acid set (95.5% [149 of 156] vs 91.7% [143 of 156] for observer 1; 96.2% [150 of 156] vs 91.0% [142 of 156] for observer 2), although there was no significant difference (P..05). In addition, sensitivity with the combined set was significantly higher than that with the gadoxetic acid set for both observers (97.1% [102 of 105] vs 91.4% [96 of 105], P =.029 for observer 1; 98.1% [103 of 105] vs 91.4% [96 of 105], P =.016 for observer 2), although there were no significant differences in specificity between the two image sets (P..05). Radiology: Volume 270: Number 3 March 2014 n radiology.rsna.org 771
5 Figure 1 Figure 1: Images in 54-year-old man with Bismuth-Corlette type IIIa hilar cholangiocarcinoma. (a) Three-dimensional MR cholangiopancreatography image shows dilatation of the intrahepatic bile duct bilaterally and separation of the right anterior and posterior and left hepatic ducts (arrows). (b) Unenhanced and (c) gadoxetic acid enhanced three-dimensional gradient-echo 3-minute delayed phase images show thickening of the bile duct at the hepatic hilum (arrow) with gradual hyperenhancement. (d) On single-shot echo-planar DW image obtained at b = 800 sec/ mm 2, the thickened hilar duct shows hyperintensity. Both observers correctly interpreted this tumor as type IIIa both before and after DW images were added to the gadoxetic acid enhanced MR image set. In the per-patient analysis of data in the 52 patients, use of the combined image set resulted in accurate diagnosis of the Bismuth-Corlette classification of 45 tumors (86.5%) and 46 tumors (88.5%) for observer 1 and observer 2, respectively, whereas use of the gadoxetic acid set resulted in correct diagnosis of 39 tumors (75.0%) and 38 tumors (73.1%) (Table 2). The addition of DW images led to correction of the Bismuth-Corlette classification, which was misclassified at the gadoxetic acid set interpretation, for eight and nine tumors for observers 1 and 2, respectively. Among tumors that were misclassified, five were misclassified with the gadoxetic acid set but were correctly classified with the combined image set by both observers (classification changed from type II to IIIa, n = 2; from type IIIa to IV, n = 1; from type IIIb to IV, n = 1; and from type IV to IIIa, n = 1). In two patients with type IIIa tumors, bile duct wall thickening or enhancement at the right secondary biliary confluence was not clearly seen on the gadoxetic acid set. However, diffusion restriction was clearly identified on DW images (Fig 2). Two type IV tumors were mutually underestimated by both observers as type IIIa and type IIIb tumors on the gadoxetic acid set. On review, in one of the patients, a small intraductal tumor Figure 2 Figure 2: Images in 70-year-old woman with Bismuth-Corlette type IIIa hilar cholangiocarcinoma. (a) Three-dimensional MR cholangiopancreatography image shows separation of the right and left hepatic ducts (arrow). (b) Gadoxetic acid enhanced portal venous phase image shows thickening of the bile duct at the hepatic hilum (arrow). Wall thickening or separation of the bilateral secondary confluence was not definite, and both observers interpreted this tumor as type II on the basis of conventional MR images. However, on (c) a DW image obtained at b = 800 sec/mm 2, the tumor is clearly seen in the hilar duct (arrow) and in the right secondary confluence (arrowheads) as areas of hyperintensity. The tumor was also seen as areas of hypointensity on the ADC map (not shown). Both observers interpreted this tumor as type IIIa after the addition of DW images to the conventional MR image set. 772 radiology.rsna.org n Radiology: Volume 270: Number 3 March 2014
6 Figure 3 Figure 3: Images in 76-year-old man with Bismuth-Corlette type IIIa hilar cholangiocarcinoma who had undergone a left percutaneous transhepatic biliary decompression procedure before MR imaging. (a, b), Gadoxetic acid enhanced portal venous phase images show thickening of the bile duct with separation of the right secondary confluence (arrow in a) and irregular narrowing of the left main duct extending to B4 (arrow in b). (c) On a T2-weighted MR image, the left secondary confluence also shows thickening and moderate hyperintensity, suggesting the possibility of tumor involvement (arrow). Both observers classified this tumor as a type IV tumor. However, (d) a DW image obtained at b = 800 sec/mm 2, as well as an ADC map (not shown), clearly displayed diffusion restriction confined to the hilar duct and the right secondary biliary confluence (arrow), so the tumor was classified as a type IIIa tumor. At pathologic examination, the thickened left secondary biliary confluence proved to be a manifestation of cholangitis. growth on the segment IV duct was clearly visible with DW images but was overlooked on the gadoxetic acid set. In the other patient, only mild and even concentric wall thickening without luminal narrowing was seen on the right secondary biliary confluence on the gadoxetic acid set. However, diffusion restriction was definite, and so the lesion was correctly classified as a type IV tumor. On the other hand, in one patient with a type IIIa tumor, the wall of the left secondary biliary confluence appeared to be thickened with signal intensity change on the gadoxetic acid set, and hence the tumor was classified as a type IV tumor. However, DW imaging clearly displayed diffusion restriction confined to the primary and right secondary biliary confluence. At pathologic examination, the wall thickening of the left secondary biliary confluence proved to be a manifestation of cholangitis (Fig 3). Both observers overestimated two type II tumors as type IIIa tumors with both image sets because wall thickening with prominent enhancement was visible at the right secondary biliary confluence on the gadoxetic acid set and diffusion restriction was present on the DW images. However, pathologic examination revealed the thickened wall of the right secondary biliary confluence to have been caused by inflammation without tumor infiltration. On the other hand, one type IV tumor and one type IIIb tumor were underestimated by both observers as type IIIa and type II tumors, respectively, with both image sets. At review, in each patient, mild and even concentric wall thickening and enhancement of the bile duct without luminal obstruction was seen at the left secondary biliary confluence on the gadoxetic acid set, but diffusion restriction was not definite. However, pathologic examination revealed submucosal spread of tumor in the bile duct. Among the two patients who had undergone percutaneous transhepatic biliary decompression procedures before MR imaging, the gadoxetic acid set in one patient (Fig 3) and both image sets in the other patient led to overestimation of the bile duct tumor extent. In addition, in nine patients, diffuse signal intensity changes in the unilateral hepatic lobe were demonstrated on T2-weighted images and gadoxetic acid enhanced images, particularly on HBP and DW images. These signal intensity changes were probably due to cholangiohepatitis and bile stasis resulting from complete ipsilateral ductal obstruction. In three of these nine patients, DW images more clearly displayed hyperintensity in the unilateral hepatic lobe than other images (Fig 4). Vascular and Liver Parenchymal Invasion Surgical and pathologic results revealed arterial invasion in 13 (25.0%) of the 52 patients (right hepatic artery, n = 7; left hepatic artery, n = 6), portal venous invasion in 10 (19.2%) patients (right portal vein, n = 3; right and main portal veins, n = 1; left portal vein, n = 6), and liver parenchymal invasion in 20 (38.5%) patients (segment IV, n = 9; segment V, n = 5; segment VIII, n = 2; segment I, n = 4). As summarized in Table 4, for assessment of vascular invasion, the combined set and the gadoxetic acid set showed similar diagnostic performances Radiology: Volume 270: Number 3 March 2014 n radiology.rsna.org 773
7 Figure 4 for both reviewers (P..05), although there were trends toward slightly improved sensitivity for the combined set compared with the gadoxetic acid set. In the evaluation of liver parenchymal invasion, the combined set (75.0% for both observers) showed significantly higher sensitivity than the gadoxetic acid set (observer 1, 50.0%; observer 2, 45.0%) (observer 1, P =.016; observer 2, P =.031) (Fig 5). Interobserver Agreement For evaluation of bile duct involvement, the two observers showed excellent interobserver agreement for both the gadoxetic acid set (weighted k = 0.897) and the combined set (weighted k = 0.896). For evaluation of vascular invasion, interobserver agreement was excellent for both the gadoxetic acid set (weighted k = for hepatic artery; weighted k = for portal vein) and the combined set (weighted k = for hepatic artery; weighted k = for portal vein). For assessment of liver Figure 4: Images in 49-year-old man with Bismuth-Corlette type II hilar cholangiocarcinoma. (a) Three-dimensional MR cholangiopancreatography image shows obstruction of the hilar duct (arrow) and dilatation of the right intrahepatic duct. (b) DW image obtained at b = 800 sec/mm 2 clearly displays hyperintensity of the right portion of the liver, indicating bile stasis associated with complete ipsilateral ductal obstruction, which was not clearly demonstrated on gadoxetic acid enhanced portal venous phase T2-weighted images (not shown) or on (c) a 20-minute HBP image. invasion, interobserver agreement was good for both the gadoxetic acid set (weighted k = 0.750) and the combined set (weighted k = 0.785). Discussion In our study, the combined sets yielded diagnostic accuracies of 95.5% (149 of 156) and 96.2% (150 of 156) for the observers for the determination of tumor extent accuracies that are slightly superior to the range of 71% 94% in previous studies (21 24). This might also indicate the benefit of adding DW imaging. Because of the excellent softtissue contrast and three-dimensional data acquisition with respiratory motion correction, the combined use of contrast material enhanced three-dimensional MR imaging and MR cholangiopancreatography has been reported to improve the diagnostic accuracy of preoperative staging of hilar cholangiocarcinoma (17,18,22,23). In addition, in our study, the high sensitivity of the combined image set for the evaluation of biliary tumor extent might be attributable to the information on the cellularity and architectural distortion of the lesion obtained from DW imaging in addition to the information obtained from conventional MR imaging. Therefore, for detecting 105 biliary confluences with tumor involvement, the sensitivity with the combined set was higher than that with the gadoxetic acid set for both observers (P,.05). Addition of DW imaging to the gadoxetic acid set led to correction of the Bismuth-Corlette classification in eight and nine patients for the two observers; these corrections were mostly of tumors that were underestimated with the gadoxetic acid set. At high b value DW imaging, most tumors (except three) were clearly demonstrated as hyperintense lesions while the background signal intensity, including that of the liver parenchyma, was suppressed. These lesions might not be clearly delineated at conventional MR imaging, particularly when fatty tissue in the hepatic hilum is not abundant or when tumor involvement approximates to the secondary biliary confluence. In addition, it might be difficult to differentiate between intraductal tumor and stones or sludge with conventional MR imaging. In that case, additional reading of DW images could be beneficial because stones and sludge showed signal suppression on high b value images. Meanwhile, we found a tendency toward overestimation of tumor extent, as well as higher rates of tumor detection, after the addition of DW images, which could explain the relatively low specificity in the evaluation of tumor extent. Given that cholangiocarcinoma develops in a stepwise carcinogenetic pathway from inflammation and biliary intraepithelial neoplasia (25), it should be acknowledged that it is difficult to distinguish chronic inflammation or precancerous lesions from superficial early cancers at both imaging and pathologic examination. In consideration of advances in surgical technique and the introduction of frozen-section biopsy during surgery, an imaging modality that provides high sensitivity for tumor detection may be more acceptable than 774 radiology.rsna.org n Radiology: Volume 270: Number 3 March 2014
8 Table 4 Sensitivity and Specificity of Gadoxetic Acid MR Image Set and Combined DW and Gadoxetic Acid MR Image Set for Predicting Vascular and Liver Parenchymal Invasion Observer and Image Set Hepatic Artery Portal Vein Liver Parenchyma Accuracy (%) Sensitivity (%) Specificity (%) Accuracy (%) Sensitivity (%) Specificity (%) Accuracy (%) Sensitivity (%) Specificity (%) Observer 1 Gadoxetic acid set 96.6 (146/156) 61.5 (8/13) [29.9, 93.1] 96.5 (138/143) [93.3, 99.7] 97.4 (152/156) 72.7 (8/11) [34.0, 100] 99.3 (144/145) [99.3, 99.3] 73.1 (38/52) 50.0 (10/20) [27.9, 72.1] 87.5 (28/32) [70.1, 95.9] Combined set 95.5 (149/156) 84.6 (11/13) [61.3, 100] 96.5 (138/143) [93.3, 99.7] 98.1 (154/156) 90.9 (11/11) [72.4, 100] 98.6 (143/145) [96.4, 100] 86.5 (45/52) 75.0 (15/20) [50.6, 90.4] 93.8 (30/32) [77.8, 98.9] P value Observer 2 Gadoxetic acid set 95.5 (149/156) 76.9 (10/13) [49.6, 100] 97.2 (139/143) [94.0, 100] 96.8 (154/156) 63.6 (7/11) [24.2, 100] 99.3 (144/145) [99.3, 99.3] 71.2 (37/52) 45.0 (9/20) [23.8, 68.0] 87.5 (28/32) [70.1, 95.9] Combined set 94.2 (147/156) 84.6 (11/13) [61.3, 100] 95.1 (136/143) [91.2, 98.9] 98.7 (155/156) 90.9 (11/11) [72.4, 100] 99.3 (144/145) [99.3, 99.3] 84.6 (44/52) 75.0 (15/20) [50.6, 90.4] 90.6 (29/32) [73.8, 97.5] P value Note. Data in parentheses are numbers of vascular segments for hepatic artery and portal vein and numbers of patients for liver parenchyma; data in brackets are 95% CIs. P values were estimated by using the generalized estimating equations method and were corrected with the Bonferroni method because of multiple testing for the hepatic artery and portal vein. The P value for specificity in the evaluation of portal vein invasion could not be assessed owing to the structure of the data. Figure 5 Figure 5: Images in 68-year-old man with Bismuth-Corlette type IV hilar cholangiocarcinoma. (a) Gadoxetic acid enhanced 3-minute delayed phase and (b) 20-minute HBP images show thickening of the hilar duct (arrow) and dilatation of the intrahepatic ducts bilaterally. (c) DW image obtained at b = 800 sec/mm 2 clearly shows a small hyperintense area (arrowhead) in segment IV adjacent to the thickened hilar duct (arrow), indicating liver invasion. This lesion (arrowhead) is also visible in b, but was missed during image interpretation. During surgery, invasion of segment IV of the liver was confirmed. one that provides high specificity in clinical practice. The accuracy of the combined image set in the determination of liver invasion was 86.5% and 84.6% for the two observers, which was higher than the 73.1% and 71.2% accuracies they achieved with the gadoxetic acid set, as well as the 80% accuracy achieved with gadolinium-enhanced 1.5-T MR imaging with MR cholangiopancreatography in a previous study (23). Particularly in patients with obstructive cholangitis, the addition of DW imaging may be helpful in detecting liver invasion, because the hepatocyte uptake of gadoxetic acid is often insufficient to delineate liver parenchymal lesions. Conversely, in our study, tumors in two patients were mutually underestimated in the two image sets by both observers, yet pathologic examination revealed submucosal tumor spread along each bile duct. The identification of submucosal tumor spread is difficult with any imaging modality, because submucosal spread cannot cause reduction of the bile duct lumen (26). In addition, the low spatial resolution of DW imaging could help explain its limited contribution in the determination of vascular invasion in the hepatic hilum, where the anatomy of the bile duct and hepatic vessels is complex. There were limitations to our study. First, because our study population Radiology: Volume 270: Number 3 March 2014 n radiology.rsna.org 775
9 included patients who underwent surgery, tumors that were considered unresectable, which would be more easily diagnosed correctly, were not included. Therefore, the overall diagnostic performance might be underestimated compared with that in daily clinical practice. On the other hand, the lack of a control population with benign biliary obstruction or inflammation might have led to overestimation of the diagnostic sensitivity. Second, because DW imaging has been recently introduced into the routine MR imaging protocol, we had no established criteria for distinguishing between bile duct cancer and cholangitis; as a result, the decisions by the observers were made subjectively. Nevertheless, the observers showed excellent agreement regarding biliary tumor involvement. Third, it is uncertain whether our results could be applicable to conventional gadolinium-enhanced MR imaging owing to different characteristics of the gadoxetic acid, especially in assessment of liver invasion. In conclusion, in the preoperative evaluation of hilar cholangiocarcinoma, the addition of DW imaging to gadoxetic acid enhanced MR imaging with MR cholangiopancreatography could improve sensitivity in the detection of tumor extent along the bile duct and the detection of liver invasion. Disclosures of Conflicts of Interest: M.J.P. No relevant conflicts of interest to disclose. Y.K.K. No relevant conflicts of interest to disclose. S.L. No relevant conflicts of interest to disclose. H.R. No relevant conflicts of interest to disclose. W.J.L. No relevant conflicts of interest to disclose. References 1. Ito F, Cho CS, Rikkers LF, Weber SM. Hilar cholangiocarcinoma: current management. Ann Surg 2009;250(2): Beazley RM, Hadjis N, Benjamin IS, Blumgart LH. Clinicopathological aspects of high bile duct cancer: experience with resection and bypass surgical treatments. Ann Surg 1984;199(6): Blumgart LH, Hadjis NS, Benjamin IS, Beazley R. Surgical approaches to cholangiocarcinoma at confluence of hepatic ducts. Lancet 1984;1(8368): Tompkins RK, Thomas D, Wile A, Longmire WP Jr. Prognostic factors in bile duct carcinoma: analysis of 96 cases. Ann Surg 1981;194(4): Hemming AW, Reed AI, Fujita S, Foley DP, Howard RJ. Surgical management of hilar cholangiocarcinoma. Ann Surg 2005; 241(5): ; discussion Dinant S, Gerhards MF, Rauws EA, Busch OR, Gouma DJ, van Gulik TM. Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor). Ann Surg Oncol 2006;13(6): Seyama Y, Kubota K, Sano K, et al. Longterm outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg 2003;238(1): Nimura Y, Kamiya J, Kondo S, et al. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg 2000;7(2): Saxena A, Chua TC, Chu FC, Morris DL. Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival. Am J Surg 2011;202(3): Klempnauer J, Ridder GJ, von Wasielewski R, Werner M, Weimann A, Pichlmayr R. Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol 1997;15(3): Igami T, Nagino M, Oda K, et al. Clinicopathologic study of cholangiocarcinoma with superficial spread. Ann Surg 2009;249(2): Wakai T, Shirai Y, Moroda T, Yokoyama N, Hatakeyama K. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer 2005; 103(6): Cui XY, Chen HW. Role of diffusion-weighted magnetic resonance imaging in the diagnosis of extrahepatic cholangiocarcinoma. World J Gastroenterol 2010;16(25): Kim MJ, Mitchell DG, Ito K, Outwater EK. Biliary dilatation: differentiation of benign from malignant causes value of adding conventional MR imaging to MR cholangiopancreatography. Radiology 2000;214(1): Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology 2010;254(1): Lee HY, Kim SH, Lee JM, et al. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology 2006;239(1): Park HS, Lee JM, Choi JY, et al. Preoperative evaluation of bile duct cancer: MRI combined with MR cholangiopancreatography versus MDCT with direct cholangiography. AJR Am J Roentgenol 2008;190(2): Ryoo I, Lee JM, Chung YE, et al. Gadobutrol-enhanced, three-dimensional, dynamic MR imaging with MR cholangiography for the preoperative evaluation of bile duct cancer. Invest Radiol 2010;45(4): Obuchowski NA. Nonparametric analysis of clustered ROC curve data. Biometrics 1997;53(2): Rao JN, Scott AJ. A simple method for the analysis of clustered binary data. Biometrics 1992;48(2): Manfredi R, Masselli G, Maresca G, Brizi MG, Vecchioli A, Marano P. MR imaging and MRCP of hilar cholangiocarcinoma. Abdom Imaging 2003;28(3): Cho ES, Park MS, Yu JS, Kim MJ, Kim KW. Biliary ductal involvement of hilar cholangiocarcinoma: multidetector computed tomography versus magnetic resonance cholangiography. J Comput Assist Tomogr 2007; 31(1): Masselli G, Manfredi R, Vecchioli A, Gualdi G. MR imaging and MR cholangiopancreatography in the preoperative evaluation of hilar cholangiocarcinoma: correlation with surgical and pathologic findings. Eur Radiol 2008;18(10): Kiryu S, Dodanuki K, Takao H, et al. Freebreathing diffusion-weighted imaging for the assessment of inflammatory activity in Crohn s disease. J Magn Reson Imaging 2009; 29(4): Zen Y, Sasaki M, Fujii T, et al. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct: an immunohistochemical study of 110 cases of hepatolithiasis. J Hepatol 2006;44(2): Bhuiya MR, Nimura Y, Kamiya J, et al. Clinicopathologic studies on perineural invasion of bile duct carcinoma. Ann Surg 1992;215(4): radiology.rsna.org n Radiology: Volume 270: Number 3 March 2014
Original article: new surgical approaches to the Klatskin tumour
Alimentary Pharmacology & Therapeutics Original article: new surgical approaches to the Klatskin tumour T. M. VAN GULIK*, S. DINANT*, O. R. C. BUSCH*, E. A. J. RAUWS, H. OBERTOP* & D. J. GOUMA Departments
More informationMRI Abdomen Protocol Pancreas/MRCP with Contrast
MRI Abdomen Protocol Pancreas/MRCP with Contrast Reviewed By: Brett Mollard, MD; Anna Ellermeier, MD Last Reviewed: July 2018 Contact: (866) 761-4200 Standard uses: 1. Characterization of cystic and solid
More informationAnatomical and Functional MRI of the Pancreas
Anatomical and Functional MRI of the Pancreas MA Bali, MD, T Metens, PhD Erasme Hospital Free University of Brussels Belgium mbali@ulb.ac.be Introduction The use of MRI to investigate the pancreas has
More informationState of the Art Imaging for Hepatic Malignancy: My Assignment
State of the Art Imaging for Hepatic Malignancy: My Assignment CT vs MR vs MRCP Which one to choose for HCC vs Cholangiocarcinoma What special protocols to use for liver tumors Role of PET and Duplex US
More information- Increased incidence? - Poor prognosis?
Imaging of Cholangiocarcinoma Amir Reza Radmard, MD Assistant Professor Shariati hospital Tehran University of medical sciences Definitions Tumors that arise from the bile duct epithelium. Accounts 10-20%
More informationIndex words : Bile duct radiography, technology Bile ducts MR Bile ducts surgery Liver, transplantation
Hilar Branching Anatomy of Living Adult Liver Donors: Comparison of T2-MR Cholangiography and Contrast Enhanced T1-MR Cholangiography in Terms of Diagnostic Utility 1 Joon Seok Lim, M.D. 1, Myeong-Jin
More informationIntraductal papillary mucinous neoplasm of the bile ducts: a rare form of premalignant lesion of invasive cholangiocarcinoma
Intraductal papillary mucinous neoplasm of the bile ducts: a rare form of premalignant lesion of invasive cholangiocarcinoma Authors: R. Revert Espí, Y. Fernandez Nuñez, I. Carbonell, D. P. Gómez valencia,
More informationMR cholangiopancreatography; Predicting imaging findings for differentiation of malignant bile ductal obstruction versus benign lesion
Acta Med Kindai Univ Vol.43, No.1 1-8, 2018 1 MR cholangiopancreatography; Predicting imaging findings for differentiation of malignant bile ductal obstruction versus benign lesion Shojiro Hidaka 1,2,
More informationHilar cholangiocarcinoma. Frank Wessels, Maarten van Leeuwen, UMCU utrecht
Hilar cholangiocarcinoma Frank Wessels, Maarten van Leeuwen, UMCU utrecht Content Anatomy Biliary strictures (Hilar) Cholangiocarcinoom Staging Biliary tract 1 st order Ductus hepatica dextra Ductus hepaticus
More informationCommon and unusual CT and MRI manifestations of pancreatic adenocarcinoma: a pictorial review
Review Article Common and unusual CT and MRI manifestations of pancreatic adenocarcinoma: a pictorial review Min-Jie Yang, Su Li, Yong-Guang Liu, Na Jiao, Jing-Shan Gong Department of Radiology, Shenzhen
More informationIs Hepatic Resection Needed in the Patients with Peritoneal Side T2 Gallbladder Cancer?
Is Hepatic Resection Needed in the Patients with Peritoneal Side T2 Gallbladder Cancer? Lee H, Park JY, Youn S, Kwon W, Heo JS, Choi SH, Choi DW Department of Surgery, Samsung Medical Center Sungkyunkwan
More informationAn Intraductal Papillary Neoplasm of the Bile Duct at the Duodenal Papilla
Published online: July 2, 2014 1662 6575/14/0072 0417$39.50/0 This is an Open Access article licensed under the terms of the Creative Commons Attribution- NonCommercial 3.0 Unported license (CC BY-NC)
More informationEffectiveness of additional resection of the invasive cancer-positive proximal bile duct margin in cases of hilar cholangiocarcinoma
Original Article Effectiveness of additional resection of the invasive cancer-positive proximal bile duct margin in cases of hilar cholangiocarcinoma Wen-Jie Ma 1#, Zhen-Ru Wu 2#, Anuj Shrestha 1,3, Qin
More informationEssentials of Clinical MR, 2 nd edition. 65. Benign Hepatic Masses
65. Benign Hepatic Masses Pulse sequences acquired for abdominal MRI typically consist of fast acquisition schemes such as single-shot turbo spin echo (i.e. HASTE) and gradient echo schemes such as FLASH
More informationIntrahepatic Sarcomatoid Cholangiocarcinoma with Portal Vein Thrombosis: A Case Report 1
Intrahepatic Sarcomatoid Cholangiocarcinoma with Portal Vein Thrombosis: A Case Report 1 Jae-Hoon Lim, M.D., Jin Woong Kim, M.D., Suk Hee Heo, M.D., Yong Yeon Jeong, M.D., Heoung Keun Kang, M.D. A 53-year-old
More informationImaging of liver and pancreas
Imaging of liver and pancreas.. Disease of the liver Focal liver disease Diffusion liver disease Focal liver disease Benign Cyst Abscess Hemangioma FNH Hepatic adenoma HCC Malignant Fibrolamellar carcinoma
More informationpitfall Table 1 4 disorientation pitfall pitfall Table 1 Tel:
11 687 692 2002 pitfall 1078 29 17 9 1 2 3 dislocation outflow block 11 1 2 3 9 1 2 3 4 disorientation pitfall 11 687 692 2002 Tel: 075-751-3606 606-8507 54 2001 8 27 2002 10 31 29 4 pitfall 16 1078 Table
More informationComparison of multidetector-row computed tomography findings of IgG4-related sclerosing cholangitis and cholangiocarcinoma
Comparison of multidetector-row computed tomography findings of IgG4-related sclerosing cholangitis and cholangiocarcinoma Poster No.: C-0245 Congress: ECR 2014 Type: Scientific Exhibit Authors: M. Yata,
More informationMRI of Small Hepatocellular Carcinoma: Typical Features Are Less Frequent Below a Size Cutoff of 1.5 cm
Gastrointestinal Imaging Original Research Choi et al. MRI of Small HCC Gastrointestinal Imaging Original Research Moon Hyung Choi 1 Joon-Il Choi 1 Young Joon Lee 1 Michael Yong Park 1 Sung Eun Rha 1 Chandana
More informationInnovations in HCC Imaging: MDCT/MRI
Innovations in HCC Imaging: MDCT/MRI Anthony E. Cheng, M.D. Cardinal MRI Center Cardinal Santos Medical Center, Wilson Street, San Juan Innovations in HCC Imaging: Goals/Objectives MDCT/MRI Learn the diagnostic
More informationContemporary Imaging of Biliary Malignancy and Preoperative Evaluation
Contemporary Imaging of Biliary Malignancy and Preoperative Evaluation Linda Pantongrag-Brown, MD Advanced Diagnostic Imaging, Ramathibodi Hospital, Bangkok, Thailand Malignancy of biliary tract Cholangiocarcinoma
More informationDiagnosis of tumor extension in biliary carcinoma has. Differential Diagnosis and Treatment of Biliary Strictures
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2009;7:S79 S83 Differential Diagnosis and Treatment of Biliary Strictures KAZUO INUI, JUNJI YOSHINO, and HIRONAO MIYOSHI Department of Internal Medicine, Second
More informationApplication of hemihepatectomy combined with vascular resection and reconstruction in bismuth III and IV hilar cholangiocarcinoma.
Biomedical Research 2017; 28 (4): 1701-1705 ISSN 0970-938X www.biomedres.info Application of hemihepatectomy combined with vascular resection and reconstruction in bismuth III and IV hilar cholangiocarcinoma.
More informationGadoxetic Acid enhanced MRI of Hepatocellular Carcinoma: Value of Washout in Transitional and Hepatobiliary Phases
ORIGINAL RESEARCH GASTROINTESTINAL IMAGING Gadoxetic Acid enhanced MRI of Hepatocellular Carcinoma: Value of Washout in Transitional and Hepatobiliary Phases Dong Hwan Kim, MD* Sang Hyun Choi, MD, PhD*
More informationImaging in gastric cancer
Imaging in gastric cancer Gastric cancer remains a deadly disease because of late diagnosis. Adenocarcinoma represents 90% of malignant tumors. Diagnosis is based on endoscopic examination with biopsies.
More informationHepatocellular carcinoma Cholangiocarcinoma. Jewels of hepatobiliary cancer imaging : what to look for? Imaging characteristics of HCC.
Outline : Imaging Jewels Jewels of hepatobiliary cancer imaging : what to look for? Hepatocellular carcinoma Cholangiocarcinoma Surachate Siripongsakun, M.D. Chulabhorn Cancer Center Imaging characteristics
More informationEffect of intravenous contrast medium administration on prostate diffusion-weighted imaging
Effect of intravenous contrast medium administration on prostate diffusion-weighted imaging Poster No.: C-1766 Congress: ECR 2015 Type: Authors: Keywords: DOI: Scientific Exhibit J. Bae, C. K. Kim, S.
More informationManagement of Cholangiocarcinoma. Roseanna Lee, MD PGY-5 Kings County Hospital
Management of Cholangiocarcinoma Roseanna Lee, MD PGY-5 Kings County Hospital Case Presentation 37 year old male from Yemen presented with 2 week history of epigastric pain, anorexia, jaundice and puritis.
More informationCholangiocarcinoma: appearances and mimics
Cholangiocarcinoma: appearances and mimics Poster No.: C-1572 Congress: ECR 2011 Type: Educational Exhibit Authors: C. Cardenas Valencia, J. Fernandez Jara, J. Cubero Carralero, B. Corral Ramos, P. Perez
More informationThe Egyptian Journal of Hospital Medicine (July 2018) Vol. 72 (11), Page
The Egyptian Journal of Hospital Medicine (July 2018) Vol. 72 (11), Page 5547-5551 The Role of Dynamic MRI with Diffusion Weighted Images in Evaluation of Portal Vein Thrombosis in Hepatic Patients 1 Suzan
More informationOriginal Research. Jung Hoon Kim, MD, Tae Kyoung Kim, MD,* Hyo Won Eun, MD, Bong Soo Kim, MD, Moon-Gyu Lee, MD, Pyo Nyun Kim, MD, and Hyun Kwon Ha, MD
JOURNAL OF MAGNETIC RESONANCE IMAGING 16:676 684 (2002) Original Research Preoperative Evaluation of Gallbladder Carcinoma: Efficacy of Combined Use of MR Imaging, MR Cholangiography, and Contrast-Enhanced
More informationMultiple Primary Quiz
Multiple Primary Quiz Case 1 A 72 year old man was found to have a 12 mm solid lesion in the pancreatic tail by computed tomography carried out during a routine follow up study of this patient with adult
More informationUsefulness of the Navigator-echo triggering Technique for Free-Breathing 3D MRCP
Usefulness of the Navigator-echo triggering Technique for Free-Breathing 3D MRCP Poster No.: C-1257 Congress: ECR 2012 Type: Scientific Exhibit Authors: K. Matsunaga, G. Ogasawara, K. Fujii, T. Irie, T.
More informationMR imaging of primary sclerosing cholangitis (PSC) using the hepatobiliary specific contrast agent Gd-EOB-DTPA
MR imaging of primary sclerosing cholangitis (PSC) using the hepatobiliary specific contrast agent Gd-EOB-DTPA Poster No.: C-0019 Congress: ECR 2010 Type: Educational Exhibit Topic: Abdominal Viscera (Solid
More informationLiver imaging takes a step forward with Ingenia
Publication for the Philips MRI Community ISSUE 49 2013 / 2 Liver imaging takes a step forward with Ingenia Lyon South Hospital strives to move from several studies first CT, then MR or PET to using just
More informationRESEARCH ARTICLE. Morphological Classification of Intraductal Papillary Neoplasm of the Bile Duct with Survival Correlation
DOI:10.22034/APJCP.2017.18.1.207 RESEARCH ARTICLE Morphological Classification of Intraductal Papillary Neoplasm of the Bile Duct with Survival Correlation Vor Luvira 1 *, Kulyada Somsap 2, Ake Pugkhem
More informationEnhancements in Hepatobiliary Imaging:
Enhancements in Hepatobiliary Imaging: S. Channual 1, MD; A. Pahwa 2, MD; S. Raman 1, MD. 1 UCLA Medical Center, Department of Radiologic Sciences 2 Olive-View UCLA Medical Center, Department of Radiology
More informationLobar and segmental liver atrophy associated with hilar cholangiocarcinoma and the impact of hilar biliary anatomical variants: a pictorial essay
Insights Imaging (2011) 2:525 531 DOI 10.1007/s13244-011-0100-9 PICTORIAL REVIEW Lobar and segmental liver atrophy associated with hilar cholangiocarcinoma and the impact of hilar biliary anatomical variants:
More informationDiffusion Weighted MR in Imaging Pancreatico-biliary & Gall Bladder Pathologies: friend or foe?
Diffusion Weighted MR in Imaging Pancreatico-biliary & Gall Bladder Pathologies: friend or foe? Poster No.: C-0595 Congress: ECR 2014 Type: Educational Exhibit Authors: K. LIM; SINGAPORE/SG Keywords: Pancreas,
More informationIntraductal malignant tumors in the liver mimicking cholangiocarcinoma: Imaging features for differential diagnosis
pissn 2287-2728 eissn 2287-285X Liver Imaging Clinical and Molecular Hepatology 2016;22:192-197 Intraductal malignant tumors in the liver mimicking cholangiocarcinoma: Imaging features for differential
More informationNon Contrast MRA. Mayil Krishnam. Director, Cardiovascular and Thoracic Imaging University of California, Irvine
Non Contrast MRA Mayil Krishnam Director, Cardiovascular and Thoracic Imaging University of California, Irvine No disclosures Non contrast MRA-Why? Limitations of CTA Radiation exposure Iodinated contrast
More informationIntraductal papillary neoplasms in the bile ducts
Intraductal papillary neoplasms in the bile ducts Seok Hwa Youn Myunghee Yoon Dong Hoon Shin Kosin University Gospel Hospital Department of general surgery Hepato-biliary-pancreatic division Introduction
More informationNote: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, conta
Note: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights. M. Fatih Akisik,
More informationTitle gadoxetic acid-enhanced MR imaging. Citation Korean journal of radiology (2013),
Title Biliary peritonitis after radiofreq gadoxetic acid-enhanced MR imaging. Author(s) Furuta, Akihiro; Isoda, Hiroyoshi; Giro; Osaki, Yukio; Togashi, Kaori Citation Korean journal of radiology (2013),
More informationOriginal Policy Date 12:2013
MP 6.01.30 Magnetic Resonance Cholangiopancreatography Medical Policy Section Radiology Is12:2013sue 3:2005 Original Policy Date 12:2013 Last Review Status/Date 12:2013 Return to Medical Policy Index Disclaimer
More informationIntraductal papillary mucinous neoplasm (IPMN)
Int Surg 2014;99:590 594 DOI: 10.9738/INTSURG-D-13-00134.1 Case Report Ruptured Intrahepatic Biliary Intraductal Papillary Mucinous Neoplasm in a Jehovah s Witness Patient Sangchul Yun 1, Dongho Choi 2
More informationDisclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None
What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Zhen Jane Wang, MD Assistant Professor in Residence UC SF Department of Radiology Disclosure None Acknowledgement Hueylan Chern, MD, Department
More informationStaging Colorectal Cancer
Staging Colorectal Cancer CT is recommended as the initial staging scan for colorectal cancer to assess local extent of the disease and to look for metastases to the liver and/or lung Further imaging for
More informationBiliary cancers: imaging diagnosis. Study of 30 cases
Biliary cancers: imaging diagnosis. Study of 30 cases N Hammoune, S Semlali, M Eddarai, T. Amil, M Zentar, S. El Kandri,, M Benameur,, S Chaouir. Radiology Department. Mohamed V Military Hospital. Rabat-
More informationProximal Bile Duct Cancer: Contemporary Management. William R. Jarnagin, MD, FACS
Proximal Bile Duct Cancer: Contemporary Management William R. Jarnagin, MD, FACS Biliary Tract Adenocarcinoma Spectrum of disease Intrahepatic (IHC) Hilar EH Gallbladder GB CBD Distal D PD Biliary Tract
More informationCase Report pissn J Korean Soc Radiol 2012;67(4): INTRODUCTION CASE REPORT
Case Report pissn 1738-2637 Focal Fat Deposition Developed in the Segment IV of the Liver Following Gastrectomy Mimicking a Hepatic Metastasis: Two Case Reports 1 위절제술후에간의제 4 분절에서발생한간전이를닮은국소지방침윤 : 두증례보고
More informationLIVER IMAGING TIPS IN VARIOUS MODALITIES. M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly
LIVER IMAGING TIPS IN VARIOUS MODALITIES M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly Hepatocellular carcinoma is a common malignancy for which prevention, screening, diagnosis,
More informationOccult mucin-producing cholangiocarcinoma in situ: a rare clinical case with difficult tumour staging
Kiriyama et al. Surgical Case Reports (2017) 3:6 DOI 10.1186/s40792-016-0283-x CASE REPORT Open Access Occult mucin-producing cholangiocarcinoma in situ: a rare clinical case with difficult tumour staging
More informationWith recent surgical techniques and devices, the
Original Article / Biliary Preoperative assessment of hilar cholangiocarcinoma: combination of cholangiography and CT angiography Shi-An Yu, Cheng Zhang, Jia-Min Zhang, Gen-Jun Mao, Long-Tang Xu, Xiao-Kang
More informationBiliary Papillomatosis: case report
Chin J Radiol 2003; 28: 407-412 407 Biliary Papillomatosis: case report CHUN-LIN HUANG WEN-PIN CHEN YU-BUN NG JOSEPH HANG LEUNG Department of Medical Imaging, Chiayi Christian Hospital Biliary papillomatosis
More informationPseudo Washout Sign in High-Flow Hepatic Hemangioma on Gadoxetic Acid Contrast-Enhanced MRI Mimicking Hypervascular Tumor
Gastrointestinal Imaging Clinical Observations Doo et al. Pseudo Washout Sign on MRI of Hemangioma Gastrointestinal Imaging Clinical Observations Kyung Won Doo 1 Chang Hee Lee Jae Woong Choi Jongmee Lee
More informationIntrahepatic cholangiocarcinoma: diffusion-weighted MR imaging findings
Intrahepatic cholangiocarcinoma: diffusion-weighted MR imaging findings Poster No.: C-1979 Congress: ECR 2013 Type: Authors: Keywords: DOI: Scientific Exhibit S. Schmidt, A. Pomoni, F. Becce, A. Denys,
More information저작자표시 2.0 대한민국 이용자는아래의조건을따르는경우에한하여자유롭게 이저작물을복제, 배포, 전송, 전시, 공연및방송할수있습니다. 이차적저작물을작성할수있습니다. 이저작물을영리목적으로이용할수있습니다. 저작자표시. 귀하는원저작자를표시하여야합니다.
저작자표시 2.0 대한민국 이용자는아래의조건을따르는경우에한하여자유롭게 이저작물을복제, 배포, 전송, 전시, 공연및방송할수있습니다. 이차적저작물을작성할수있습니다. 이저작물을영리목적으로이용할수있습니다. 다음과같은조건을따라야합니다 : 저작자표시. 귀하는원저작자를표시하여야합니다. 귀하는, 이저작물의재이용이나배포의경우, 이저작물에적용된이용허락조건을명확하게나타내어야합니다.
More informationPost-operative complications following hepatobiliary surgery: imaging findings and current radiological treatment options
Post-operative complications following hepatobiliary surgery: imaging findings and current radiological treatment options Poster No.: C-1501 Congress: ECR 2015 Type: Educational Exhibit Authors: A. Hadjivassiliou,
More informationCT Differentiation of Mucin- Producing Cystic Neoplasms of the Liver From Solitary Bile Duct Cysts
Gastrointestinal Imaging Original Research Kim et al. CT of Hepatic Cystic Neoplasms and Cysts Gastrointestinal Imaging Original Research Hyoung Jung Kim 1 Eun Sil Yu 2 Jae Ho Byun 1 Seung-Mo Hong 2 Kyoung
More informationTitle: Painless jaundice as an initial presentation of lung adenocarcinoma
Title: Painless jaundice as an initial presentation of lung adenocarcinoma Authors: Irene Andaluz García, Irene González Partida, Javier Lucas Ramos, Jorge Yebra Carmona DOI: 10.17235/reed.2018.5587/2018
More informationFactors associated with T2 Shine-Through Effect in Hepatic Hemangiomas on Diffusion-weighted MR Sequences
Factors associated with T Shine-Through Effect in Hepatic Hemangiomas on Diffusion-weighted MR Sequences Poster No.: C-09 Congress: ECR 014 Type: Scientific Exhibit Authors: R. Duran, M. Ronot, A. kerbaol,
More informationThe Low Sensitivity of Fluid-Attenuated Inversion-Recovery MR in the Detection of Multiple Sclerosis of the Spinal Cord
The Low Sensitivity of Fluid-Attenuated Inversion-Recovery MR in the Detection of Multiple Sclerosis of the Spinal Cord Mark D. Keiper, Robert I. Grossman, John C. Brunson, and Mitchell D. Schnall PURPOSE:
More informationReview. Computed tomography in the diagnosis and staging of cholangiocarcinoma and pancreatic carcinoma
Annals of Oncology 10 Suppl. 4: S12-S17, 1999. 1999 Kluwer Academic Publishers. Printed in the Netherlands. Review Computed tomography in the diagnosis and staging of cholangiocarcinoma and pancreatic
More informationCorrect Diagnosis of Vascular Encasement and Longitudinal Extension of Hilar Cholangiocarcinoma by Four-Channel Multidetector-Row Computed Tomography
Tohoku J. Exp. Med., 2009, 217, Diagnosis 1-8 of Hilar Cholangiocarcinoma by Multidetector-Row CT 1 Correct Diagnosis of Vascular Encasement and Longitudinal Extension of Hilar Cholangiocarcinoma by Four-Channel
More informationCT & MRI of Benign Liver Neoplasms Srinivasa R Prasad
CT & MRI of Benign Liver Neoplasms Srinivasa R Prasad No financial disclosures Acknowledgements Many thanks to Drs. Heiken, Narra & Menias (MIR) Dr. Sahani (MGH) for sharing images Benign Liver Tumors:
More informationDiffusion-Weighted Imaging of Prostate Cancer
ORIGINAL ARTICLE Diffusion-Weighted Imaging of Prostate Cancer Ryota Shimofusa, MD,* Hajime Fujimoto, MD, Hajime Akamata, MD, Ken Motoori, MD,* Seiji Yamamoto, MD,* Takuya Ueda, MD,* and Hisao Ito, MD*
More informationEndoscopic Ultrasonography Assessment for Ampullary and Bile Duct Malignancy
Diagnostic and Therapeutic Endoscopy, Vol. 3, pp. 35-40 Reprints available directly from the publisher Photocopying permitted by license only (C) 1996 OPA (Overseas Publishers Association) Amsterdam B.V.
More informationCase Report Intrabiliary Hepatic Metastasis of Colorectal Carcinoma Mimicking Primary Cholangiocarcinoma: A Case Report and Review of the Literature
Case Reports in Pathology Volume 2016, Article ID 4704781, 5 pages http://dx.doi.org/10.1155/2016/4704781 Case Report Intrabiliary Hepatic Metastasis of Colorectal Carcinoma Mimicking Primary Cholangiocarcinoma:
More informationMR Imaging Findings of Early Bile Duct Cancer
JOURNAL OF MAGNETIC RESONANCE IMAGING 28:1466 1475 (2008) Original Research MR Imaging Findings of Early Bile Duct Cancer Dong Ho Lee, MD, Jeong Min Lee, MD,* Kyung Won Kim, MD, Hee Sun Park, MD, Se Hyung
More informationCommon Occurrence of Benign Liver Lesions in Patients With Newly Diagnosed Breast Cancer Investigated by MRI for Suspected Liver Metastases
JOURNAL OF MAGNETIC RESONANCE IMAGING 10:165 169 (1999) Original Research Common Occurrence of Benign Liver Lesions in Patients With Newly Diagnosed Breast Cancer Investigated by MRI for Suspected Liver
More informationClinical Correlation of a New Practical MRI Method for Assessing Cervical Spinal Canal Compression
Musculoskeletal Imaging Original Research Park et al. MRI Assessment of Cervical Spinal Canal Compression Musculoskeletal Imaging Original Research Hee-Jin Park 1,2 Sam Soo Kim 2 Eun-Chul Chung 1 So-Yeon
More informationIndex terms: Liver, CT Liver neoplasm, CT. Korean J Radiol 2005;6: Received February 21, 2005; accepted after revision May 24, 2005.
Depiction of Viable Tumor in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: Multiphasic Helical CT with Review of the Previous Serial CT Images Kyung Mi Jang, MD 1 Dongil Choi,
More informationYurong Liang, Jing Wang, Xianjie Shi, Jiahong Dong, and Wanqing Gu. 1. Introduction. 2. Patients and Methods
Gastroenterology Research and Practice Volume 2015, Article ID 934565, 4 pages http://dx.doi.org/10.1155/2015/934565 Clinical Study Application of a Gastroduodenal Artery Graft for Reconstruction of the
More informationComparison of T2-weighted MRCP before and after injection of Gd-EOB-DTPA in patients with primary sclerosing cholangitis (PSC)
Comparison of T2-weighted MRCP before and after injection of Gd-EOB-DTPA in patients with primary sclerosing cholangitis (PSC) Poster No.: C-0051 Congress: ECR 2010 Type: Scientific Exhibit Topic: Abdominal
More informationCaroli s disease: magnetic resonance imaging features
Eur Radiol (2002) 12:2730 2736 DOI 10.1007/s00330-002-1471-6 HEPATOBILIARY PANCREAS France Guy François Cognet Marie Dranssart Jean-Pierre Cercueil Laurent Conciatori Denis Krausé Caroli s disease: magnetic
More informationNEW SUBTRACTION ALGORITHMS FOR EVALUATION OF BREAST LESIONS ON DYNAMIC CONTRAST ENHANCED MR MAMMOGRAPHY
A-056 NEW SUBTRACTION ALGORITHMS FOR EVALUATION OF BREAST LESIONS ON DYNAMIC CONTRAST ENHANCED MR MAMMOGRAPHY So Hee Cho, M.D., Byung Gil Choi, M.D., Hak Hee Kim, M.D., Euy Neyng Kim, M.D., Bum-soo Kim,
More informationBiliary MRI w Eovist
Biliary MRI w Eovist Is there any added value? Elmar M. Merkle, MD Director of MR Imaging Duke University Medical Center elmar.merkle@duke.edu Declaration of Conflict of Interest or Relationship Research
More informationRECENT ADVANCES IN CLINICAL MR OF ARTICULAR CARTILAGE
In Practice RECENT ADVANCES IN CLINICAL MR OF ARTICULAR CARTILAGE By Atsuya Watanabe, MD, PhD, Director, Advanced Diagnostic Imaging Center and Associate Professor, Department of Orthopedic Surgery, Teikyo
More informationROLE OF RADIOLOGY IN INVESTIGATION OF JAUNDICE
ROLE OF RADIOLOGY IN INVESTIGATION OF JAUNDICE Dr. Sohan kumar sah *, Dr. Liu Sibin, Dr. sumendra raj pandey, Dr. Prakashmaan shah, Dr. Gaurishankar pandit, Dr. Suraj kurmi and Dr. Sanjay kumar jaiswal
More informationPredictive factors for invasive intraductal papillary mucinous neoplasm of the pancreas
Korean J Hepatobiliary Pancreat Surg 2011;15:27-22 Original Article Predictive factors for invasive intraductal papillary mucinous neoplasm of the pancreas Dae Young Jun 1, Hyung Jun Kwon 2, Sang Geol
More informationWhat Is the Current State-of-the-Art Imaging for Detection and Staging of Cholangiocarcinoma? James M. Slattery, Dushyant V.
Hepatobiliary What Is the Current State-of-the-Art Imaging for Detection and Staging of Cholangiocarcinoma? James M. Slattery, Dushyant V. Sahani Division of Abdominal Imaging and Interventional Radiology,
More informationHEPATOCYTE SPECIFIC CONTRAST MEDIA: WHERE DO WE STAND?
HEPATOCYTE SPECIFIC CONTRAST MEDIA: WHERE DO WE STAND? Andrew T. Trout, MD @AndrewTroutMD Disclosures No relevant disclosures Outline Review of hepatocyte specific contrast media Review of hepatocellular
More informationCase Reports: Tumor Detection by Diffusion-Weighted MRI and ADC-Mapping with Correlation to PET/CT Results
Case Reports: Tumor Detection by Diffusion-Weighted MRI and ADC-Mapping with Correlation to PET/CT Results Matthias Philipp Lichy, M.D.; Philip Aschoff, M.D.; Christina Pfannenberg, M.D.; Schlemmer Heinz-Peter,
More informationRole of resection for Bismuth type IV hilar cholangiocarcinoma and analysis of determining factors for curative resection
ORIGINAL ARTICLE pissn 2288-6575 eissn 2288-6796 http://dx.doi.org/10.4174/astr.2014.87.2.87 Annals of Surgical Treatment and Research Role of resection for Bismuth type IV hilar cholangiocarcinoma and
More informationMR Advance Techniques. Vascular Imaging. Class II
MR Advance Techniques Vascular Imaging Class II 1 Vascular Imaging There are several methods that can be used to evaluate the cardiovascular systems with the use of MRI. MRI will aloud to evaluate morphology
More informationCholangiocarcinoma (Bile Duct Cancer)
Cholangiocarcinoma (Bile Duct Cancer) The Bile Duct System (Biliary Tract) A network of bile ducts (tubes) connects the liver and the gallbladder to the small intestine. This network begins in the liver
More informationCongenital dilatation of the common bile duct and pancreaticobiliary maljunction clinical implications
Langenbecks Arch Surg (2009) 394:209 213 DOI 10.1007/s00423-008-0330-6 CURRENT CONCEPT IN CLINICAL SURGERY Congenital dilatation of the common bile duct and pancreaticobiliary maljunction clinical implications
More informationCurrent Treatment Strategies for Hilar and Intrahepatic Cholangiocarcinoma
Current Treatment Strategies for Hilar and Intrahepatic Cholangiocarcinoma Jean-Nicolas Vauthey, MD, FACS Professor of Surgery Chief Hepato-Pancreato-Biliary Section Department of Surgical Oncology Crescent
More informationDifferential Diagnosis of Benign and Malignant Intraductal Papillary Mucinous Tumors of the Pancreas: MR Cholangiopancreatography
Differential Diagnosis of Benign and Malignant Intraductal Papillary Mucinous Tumors of the Pancreas: MR Cholangiopancreatography and MR Angiography Byung Se Choi, MD 1 Tae Kyoung Kim, MD 1 Ah Young Kim,
More informationPortal Vein in a Patient Undergoing Hepatic Resection
HPB Surgery, 1997, Vol. 10, pp. 323-327 Reprints available directly from the publisher Photocopying permitted by license only (C) 1997 OPA (Overseas Publishers Association) Amsterdam B.V. Published in
More informationLiver related complications in unresectable disease after portal vein embolization
Original Article Liver related complications in unresectable disease after portal vein embolization Floor Huisman 1, Kasia P. Cieslak 1, Krijn P. van Lienden 2, Roelof J. Bennink 3, Thomas M. van Gulik
More informationOptimal Bile Duct Division Using Real- Time Indocyanine Green Near-Infrared Fluorescence Cholangiography During Laparoscopic Donor Hepatectomy
LETTERS FROM THE FRONTLINE Optimal Bile Duct Division Using Real- Time Indocyanine Green Near-Infrared Fluorescence Cholangiography During Laparoscopic Donor Hepatectomy TO THE EDITOR: Despite advances
More informationGeneral summary GENERAL SUMMARY
General summary GENERAL SUMMARY In Chapter 2.1 the long-term results and prognostic factors of radiofrequency ablation (RFA) for unresectable colorectal liver metastases (CRLM) in a single center with
More informationPostoperative Chylothorax: the Use of Dynamic Magnetic Resonance Lymphangiography and Thoracic Duct Embolization
pissn 2384-1095 eissn 2384-1109 imri 2018;22:182-186 Postoperative Chylothorax: the Use of Dynamic Magnetic Resonance Lymphangiography and Thoracic Duct Embolization Chae Woon Lee, Hyun Jung Koo, Ji Hoon
More informationRole of Gd-EOB-DTPA enhanced MR Imaging in the evaluation of the transplanted liver: Advantages and Limitations
Role of Gd-EOB-DTPA enhanced MR Imaging in the evaluation of the transplanted liver: Advantages and Limitations Robinson Yu, MD, Amir A. Borhani, MD, Alessandro Furlan, MD, Matthew T. Heller, MD, Mitchell
More informationNewcastle HPB MDM updated radiology imaging protocol recommendations. Author Dr John Scott. Consultant Radiologist Freeman Hospital
Newcastle HPB MDM updated radiology imaging protocol recommendations Author Dr John Scott. Consultant Radiologist Freeman Hospital This document is intended as a guide to aid radiologists and clinicians
More informationDifferentiating small arterial only enhancing hepatocellular carcinoma from nontumorous arteroportal shunt with an emphasis on the precontrast phase
Differentiating small arterial only enhancing hepatocellular carcinoma from nontumorous arteroportal shunt with an emphasis on the precontrast phase Poster No.: C-0739 Congress: ECR 2015 Type: Scientific
More informationDiffusion Weighted Imaging in Prostate Cancer
Diffusion Weighted Imaging in Prostate Cancer Disclosure Information Vikas Kundra, M.D, Ph.D. No financial relationships to disclose. Education Goals and Objectives To describe the utility of diffusion-weighted
More informationRole of imaging in RCC. Ultrasonography. Solid lesion. Cystic RCC. Solid RCC 31/08/60. From Diagnosis to Treatment: the Radiologist Perspective
Role of imaging in RCC From Diagnosis to Treatment: the Radiologist Perspective Diagnosis Staging Follow up Imaging modalities Limitations and pitfalls Duangkamon Prapruttam, MD Department of Therapeutic
More information